Cytarabine Injection BP

Product Description

Cytalon 1000 Injection is usedto treat some kinds of cancers of blood. It may be also used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.

1. What is Cytarabine Injection BP?

   • Cytarabine Injection BP is a medication used in the treatment of certain types of cancer, including leukemia (such as acute myeloid leukemia and acute lymphoblastic leukemia) and lymphoma.

2. How does Cytarabine Injection BP work?

   • Cytarabine works by interfering with the growth and spread of cancer cells in the body. It is a type of chemotherapy drug known as an antimetabolite, which means it disrupts the process of DNA synthesis in rapidly dividing cells, ultimately leading to cell death.

3. How is Cytarabine Injection BP administered?

   • Cytarabine Injection BP is typically administered intravenously (IV) or subcutaneously (under the skin) by a healthcare professional in a hospital or clinic setting. The dosage and frequency of administration will be determined by your healthcare provider based on your individual condition and response to treatment.

4. What types of cancer is Cytarabine Injection BP used to treat?

   • Cytarabine Injection BP is commonly used to treat leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It may also be used in the treatment of certain types of lymphoma, such as non-Hodgkin lymphoma.

5. What are the common side effects of Cytarabine Injection BP?

   • Common side effects may include nausea, vomiting, diarrhea, loss of appetite, hair loss, fatigue, mouth sores, and bone marrow suppression (leading to low blood cell counts). These side effects are usually temporary and may improve with time or with supportive care medications.

6. Are there any serious side effects I should be aware of?

   • Yes, Cytarabine Injection BP can cause serious side effects, including increased risk of infections due to low white blood cell counts, bleeding due to low platelet counts, and anemia due to low red blood cell counts. It may also cause inflammation of the lining of the mouth and digestive tract (mucositis), which can be painful and may require treatment.

7. Who should not receive Cytarabine Injection BP?

   • Cytarabine Injection BP may not be suitable for everyone. It should not be used in patients with a known allergy to cytarabine or any of the ingredients in the medication. It should also be used with caution in patients with certain medical conditions, such as kidney or liver impairment.

8. Can Cytarabine Injection BP interact with other medications?

   • Yes, Cytarabine Injection BP can interact with certain medications, including other chemotherapy drugs and medications that affect bone marrow function. Inform your healthcare provider about all medications, supplements, and herbal remedies you are taking before starting Cytarabine treatment.

9. How should Cytarabine Injection BP be stored?

   • It should be stored at room temperature (20-25C) away from light and moisture. Follow the specific storage instructions provided by your pharmacist.

 

Key Features and Compliance

Cytarabine Injection BP stands out due to its compliance with BP standards and its reliable sterile, pyrogen-free composition. Each glass vial contains a clear, colorless solution, precisely formulated for intravenous or subcutaneous use in cancer therapy. Its USP-compliant manufacturing ensures safety, efficacy, and consistent quality.


Strengths and Packaging

The injection is available in strengths of 100 mg/1 ml, 500 mg/10 ml, and 1000 mg/20 ml, each provided in a single-dose glass vial. These options enable precise dosing according to medical requirements, enhancing convenience and treatment customization for healthcare professionals.


Storage, Handling, and Shelf Life

To ensure maximum efficacy, Cytarabine Injection BP should be stored below 25C and kept protected from light. When handled and stored appropriately, the product offers a shelf life of 24 months, making it suitable for bulk supply and export as well as routine medical use.